Quick Answer ANALOG DEVICES INC reported Diluted EPS of $4.56 per share for fiscal year 2025. ANALOG DEVICES INC Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $4.56 +39.0% 2024 $3.28 -49.9% 2023 $6.55 +24.8% 2022 $5.25 +51.7% 2021 $3.46 +5.5% 2020 $3.28 +53.3% 2013 $2.14 +0.5% 2012 $2.13 -24.2% 2011 … Read more
Quick Answer ANALOG DEVICES INC reported Revenue (ASC 606) of $11.02 billion for fiscal year 2025. ANALOG DEVICES INC Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $11.02B +16.9% 2024 $9.43B -23.4% 2023 $12.31B +2.4% 2022 $12.01B +64.2% 2021 $7.32B +30.6% 2020 $5.60B -6.5% 2019 $5.99B -3.8% 2018 $6.22B … Read more
Quick Answer ANALOG DEVICES INC reported Total Revenue of $11.02 billion for fiscal year 2025. ANALOG DEVICES INC Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $11.02B +16.9% 2024 $9.43B -23.4% 2023 $12.31B +2.4% 2022 $12.01B +64.2% 2021 $7.32B +30.6% 2020 $5.60B -6.5% 2019 $5.99B -3.4% 2018 $6.20B +21.4% 2017 $5.11B … Read more
Quick Answer ANALOG DEVICES INC reported Total Revenue of $11.02 billion for fiscal year 2025. ANALOG DEVICES INC — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $11.02B+16.9% $9.43B-23.4% $12.31B+2.4% $12.01B+64.2% $7.32B+30.6% $5.60B-6.5% Revenue (ASC 606) $11.02B+16.9% $9.43B-23.4% $12.31B+2.4% $12.01B+64.2% $7.32B+30.6% $5.60B-6.5% Net Income $2.27B+38.7% $1.64B-50.7% $3.31B+20.6% $2.75B+97.7% $1.39B+13.9% $1.22B-10.4% … Read more
Quick Answer Adagio Medical Holdings, Inc. reported Operating Income of -$21.89 million for fiscal year 2025. Adagio Medical Holdings, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$21.89M +21.7% 2023 -$27.94M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$5.72M -29.3% -21.3% June 30, 2025 … Read more
Quick Answer Adagio Medical Holdings, Inc. reported Shares Outstanding of 22.21 million shares for fiscal year 2025. Adagio Medical Holdings, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 22.21M +46.1% 2024 15.20M +1848.7% 2024 779,908 +0.0% 2023 779,908 — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, … Read more
Quick Answer Adagio Medical Holdings, Inc. reported R&D Expense of $10.64 million for fiscal year 2025. Adagio Medical Holdings, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $10.64M -30.9% 2023 $15.40M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, 2025 $2.77M +127.9% +40.7% June 30, 2025 … Read more
Quick Answer Adagio Medical Holdings, Inc. reported Stockholders Equity of $12.40 million for fiscal year 2025. Adagio Medical Holdings, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $12.40M -37.7% 2024 $19.91M -72.7% 2024 $72.96M +155.3% 2023 -$132.02M -37.7% 2022 -$95.88M — Quarterly Stockholders Equity Quarter Ending Stockholders Equity YoY QoQ … Read more
Quick Answer Adagio Medical Holdings, Inc. reported Cash and Equivalents of $17.11 million for fiscal year 2025. Adagio Medical Holdings, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $17.11M -16.9% 2024 $20.59M +1388.5% 2023 $1.38M — Quarterly Cash and Equivalents Quarter Ending Cash and Equivalents YoY QoQ September … Read more
Quick Answer Adagio Medical Holdings, Inc. reported Diluted EPS of $1.51 per share (loss) for fiscal year 2025. Adagio Medical Holdings, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$1.51 +96.9% 2023 -$48.16 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, 2025 -$0.66 -3400.0% -88.6% June … Read more